Shenzhen New Industries Biomedical Engineering Co., Ltd.
300832
Rank in Stocks
#2881
Shenzhen New Industries Biomedical Engineering Co., Ltd., engages in the... Shenzhen New Industries Biomedical Engineering Co., Ltd., engages in the research, development, production, and sale of clinical laboratory instruments and in vitro diagnostic reagents to hospitals in China and internationally. It offers immunoassay machine, biochemistry/electrolyte, integrated system, lab automation, molecular diagnostics, hemolumi and rapid test solutions. The company was founded in 1995 and is based in Shenzhen, China.
Share Price
$8.03
Market Cap
$6.31B
Change (1 day)
1.07%
Change (1 year)
-8.04%
Country
CN
Trade Shenzhen New Industries Biomedical Engineering Co., Ltd. (300832)
Category
Healthcare
Earnings for Shenzhen New Industries Biomedical Engineering Co., Ltd. (300832)
Earnings in Jun 2026 TTM: $294.96M
According to Shenzhen New Industries Biomedical Engineering Co., Ltd. latest financial reports the company's current earnings are $294.96M. In 2024 the company made an earning of $286.77M, an increase over its 2023 earnings that were of $267.43M. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Shenzhen New Industries Biomedical Engineering Co., Ltd. from 2012 to 2026
Earnings at the end of each year
| Year | Earnings | Change |
|---|---|---|
| 2026 (TTM) | $294.96M | 11.23% |
| 2025 | $265.17M | -7.53% |
| 2024 | $286.77M | 7.23% |
| 2023 | $267.43M | 22.88% |
| 2022 | $217.63M | 21.82% |
| 2021 | $178.66M | 6.41% |
| 2020 | $167.89M | 30.12% |
| 2019 | $129.03M | 9.95% |
| 2018 | $117.35M | 21.27% |
| 2017 | $96.77M | 27.14% |
| 2016 | $76.11M | 69.74% |
| 2015 | $44.84M | -6.42% |
| 2014 | $47.91M | 76.41% |
| 2013 | $27.16M | 94.24% |
| 2012 | $13.98M | 0.00% |
Earnings for similar companies or competitors
| Company | Earnings | Earnings Difference | Country |
|---|---|---|---|
| $6.56B | 2,124.73% |
US
|
|
| $6.60B | 2,138.63% |
IE
|
|
| $5.15B | 1,645.34% |
US
|
|
| $3.86B | 1,209.00% |
US
|
|
| $3.25B | 1,001.86% |
DE
|
